Human embryonic stem cell technologies and drug discovery

Development of new drugs is costly and takes huge resources into consideration. The big pharmaceutical companies are currently facing increasing developmental costs and a lower success‐rate of bringing new compounds to the market. Therefore, it is now of outmost importance that the drug‐hunting companies minimize late attritions due to sub‐optimal pharmacokinetic properties or unexpected toxicity when entering the clinical programs. To achieve this, a strong need to test new candidate drugs in assays of high human relevance in vitro as early as possible has been identified. The traditionally used cell systems are however remarkably limited in this sense, and new improved technologies are of greatest importance. The human embryonic stem cells (hESC) is one of the most powerful cell types known. They have not only the possibility to divide indefinitely; these cells can also differentiate into all mature cell types of the human body. This makes them potentially very valuable for pharmaceutical development, spanning from use as tools in early target studies, DMPK or safety assessment, as screening models to find new chemical entities modulating adult stem cell fate, or as the direct use in cell therapies. This review illustrates the use of hESC in the drug discovery process, today, as well as in a future perspective. This will specifically be exemplified with the most important cell type for pharmaceutical development—the hepatocyte. We discuss how hESC‐derived hepatocyte‐like cells could improve this process, and how these cells should be cultured if optimized functionality and usefulness should be achieved. J. Cell. Physiol. 219: 513–519, 2009. © 2009 Wiley‐Liss, Inc.

[1]  Karin Noaksson,et al.  Facilitated Expansion of Human Embryonic Stem Cells by Single‐Cell Enzymatic Dissociation , 2007, Stem cells.

[2]  David J. Williams,et al.  Automated, scalable culture of human embryonic stem cells in feeder‐free conditions , 2009, Biotechnology and bioengineering.

[3]  David C Hay,et al.  Efficient Differentiation of Hepatocytes from Human Embryonic Stem Cells Exhibiting Markers Recapitulating Liver Development In Vivo , 2008, Stem cells.

[4]  J. Itskovitz‐Eldor,et al.  Directed differentiation of human embryonic stem cells into functional hepatic cells , 2007, Hepatology.

[5]  D. Kaufman,et al.  Improved development of human embryonic stem cell‐derived embryoid bodies by stirred vessel cultivation , 2006, Biotechnology and bioengineering.

[6]  H. Mizumoto,et al.  Hepatic differentiation of mouse embryonic stem cells in a three-dimensional culture system using polyurethane foam. , 2008, Journal of bioscience and bioengineering.

[7]  P. Alves,et al.  Towards an extended functional hepatocyte in vitro culture. , 2009, Tissue engineering. Part C, Methods.

[8]  Hossein Baharvand,et al.  Differentiation of human embryonic stem cells into hepatocytes in 2D and 3D culture systems in vitro. , 2006, The International journal of developmental biology.

[9]  Ying Meng,et al.  Differentiation and Enrichment of Hepatocyte‐Like Cells from Human Embryonic Stem Cells In Vitro and In Vivo , 2007, Stem cells.

[10]  E. Kroon,et al.  Production of pancreatic hormone–expressing endocrine cells from human embryonic stem cells , 2006, Nature Biotechnology.

[11]  Peter Neuhaus,et al.  Three-dimensional Co-culture of Primary Human Liver Cells in Bioreactors for In Vitro Drug Studies: Effects of the Initial Cell Quality on the Long-term Maintenance of Hepatocyte-specific Functions , 2002, Alternatives to laboratory animals : ATLA.

[12]  Smadar Cohen,et al.  Induced differentiation and maturation of newborn liver cells into functional hepatic tissue in macroporous alginate scaffolds , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  B. Olsson,et al.  Molecular Signature of Cardiomyocyte Clusters Derived from Human Embryonic Stem Cells , 2008, Stem cells.

[14]  Janet Rossant,et al.  The International Stem Cell Initiative: toward benchmarks for human embryonic stem cell research , 2005, Nature Biotechnology.

[15]  Maria Bokhari,et al.  Novel cell culture device enabling three-dimensional cell growth and improved cell function. , 2007, Biochemical and biophysical research communications.

[16]  Peter Neuhaus,et al.  Use of primary human liver cells originating from discarded grafts in a bioreactor for liver support therapy and the prospects of culturing adult liver stem cells in bioreactors: a morphologic study , 2003, Transplantation.

[17]  M. Bradley,et al.  Organotypic cultures as tools for functional screening in the CNS. , 2005, Drug discovery today.

[18]  Catherine Payne,et al.  Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling , 2008, Proceedings of the National Academy of Sciences.

[19]  Yukio Nakamura,et al.  A Method for the Selection of Human Embryonic Stem Cell Sublines with High Replating Efficiency After Single‐Cell Dissociation , 2006, Stem cells.

[20]  Phillip C. Yang,et al.  In vitro differentiation of mouse embryonic stem (mES) cells using the hanging drop method. , 2008, Journal of visualized experiments : JoVE.

[21]  Robert Lanza,et al.  Efficient Differentiation of Functional Hepatocytes from Human Embryonic Stem Cells , 2008, Stem cells.

[22]  Maria Bokhari,et al.  Culture of HepG2 liver cells on three dimensional polystyrene scaffolds enhances cell structure and function during toxicological challenge , 2007, Journal of anatomy.

[23]  Hayley S. Brown,et al.  Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies , 2007, Drug metabolism reviews.

[24]  G. Hamilton,et al.  Regulation of cell morphology and cytochrome P450 expression in human hepatocytes by extracellular matrix and cell-cell interactions , 2001, Cell and Tissue Research.

[25]  Pratima Kundu,et al.  Generation of Hepatocyte-Like Cells from Human Embryonic Stem Cells , 2003, Cell transplantation.

[26]  Anders Lindahl,et al.  Human embryonic stem cells: current technologies and emerging industrial applications. , 2008, Critical reviews in oncology/hematology.

[27]  L Gepstein,et al.  Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. , 2001, The Journal of clinical investigation.

[28]  J. Encke,et al.  Bioreactor for a larger scale hepatocyte in vitro perfusion. , 1994, Transplantation.

[29]  Eugenia Kumacheva,et al.  Generation of human embryonic stem cell‐derived mesoderm and cardiac cells using size‐specified aggregates in an oxygen‐controlled bioreactor , 2009, Biotechnology and bioengineering.

[30]  Smadar Cohen,et al.  Liver tissue engineering within alginate scaffolds: effects of cell-seeding density on hepatocyte viability, morphology, and function. , 2003, Tissue engineering.

[31]  P. Sartipy,et al.  Molecular and Pharmacological Properties of Human Embryonic Stem Cell–Derived Cardiomyocytes , 2006, Experimental biology and medicine.

[32]  M. Toner,et al.  Effect of extracellular matrix topology on cell structure, function, and physiological responsiveness: hepatocytes cultured in a sandwich configuration , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  P. Maurel.  The use of adult human hepatocytes in primary culture and other in vitro systems to investigate drug metabolism in man , 1996 .

[34]  Jaesung Park,et al.  Homogeneous differentiation of hepatocyte‐like cells from embryonic stem cells: applications for the treatment of liver failure , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  J. Hyllner,et al.  Low molecular weight compounds for in vitro fate determination of human embryonic stem cells. , 2008, Pharmacological research.

[36]  B. Jernström,et al.  Glutathione transferases in hepatocyte-like cells derived from human embryonic stem cells. , 2007, Toxicology in vitro : an international journal published in association with BIBRA.

[37]  W. Miller,et al.  Bioreactor development for stem cell expansion and controlled differentiation. , 2007, Current opinion in chemical biology.

[38]  Martin L Yarmush,et al.  Three-dimensional primary hepatocyte culture in synthetic self-assembling peptide hydrogel. , 2008, Tissue engineering. Part A.

[39]  R. Tompkins,et al.  Long‐Term in Vitro Function of Adult Hepatocytes in a Collagen Sandwich Configuration , 1991, Biotechnology progress.

[40]  Peter Sartipy,et al.  The application of human embryonic stem cell technologies to drug discovery. , 2007, Drug discovery today.

[41]  Yitao Ding,et al.  Bioartificial liver inoculated with porcine hepatocyte spheroids for treatment of canine acute liver failure model. , 2003, Artificial organs.

[42]  I. Kola,et al.  Can the pharmaceutical industry reduce attrition rates? , 2004, Nature Reviews Drug Discovery.

[43]  J. Itskovitz‐Eldor,et al.  Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[44]  H. Baharvand,et al.  Differentiation of human embryonic stem cells into functional hepatocyte-like cells in a serum-free adherent culture condition. , 2008, Differentiation; research in biological diversity.

[45]  J. Itskovitz‐Eldor,et al.  Three‐dimensional porous alginate scaffolds provide a conducive environment for generation of well‐vascularized embryoid bodies from human embryonic stem cells , 2004, Biotechnology and bioengineering.

[46]  Smadar Cohen,et al.  Enhancing the drug metabolism activities of C3A--a human hepatocyte cell line--by tissue engineering within alginate scaffolds. , 2006, Tissue engineering.

[47]  Peter Neuhaus,et al.  Time course of primary liver cell reorganization in three-dimensional high-density bioreactors for extracorporeal liver support: an immunohistochemical and ultrastructural study. , 2004, Tissue engineering.